Pilot Study: AI Algorithm for Dermatology Referral Optimization
DAO_DERIVATION
Pilot Study for the Clinical Validation of an Artificial Intelligence Algorithm to Optimize the Appropriateness of Dermatology Referrals.
1 other identifier
observational
200
1 country
1
Brief Summary
The goal of this observational prospective and analytical study is to validate that the device is a valid tool for improving the adequacy of referrals to dermatology. As a secondary objectives the investigators set out to validate that the device reduces costs in secondary care; to validate that the device reduces dermatology waiting lists and to validate that the device optimizes clinical flow in Osakidetza. The primary care physician will explain to the patient what his/her participation in the study will consist of by means of the Patient Information Sheet. The patient, in turn, will be able to ask all the questions he/she considers appropriate in order to clarify all his/her doubts regarding the study. If the patient wishes to participate in the study, he/she will sign the Informed Consent Form and will be assigned a study code. After signing the informed consent, the data collection process begins. The Principal Investigator and/or collaborating investigators assigned to this task will collect demographic data (age, sex) and data related to the diagnosis, characteristics and treatment of the pathology. Primary care physicians should take photographs showing the areas affected by the pathology. These photographs will be taken with their own smartphone or using a mobile dermatoscope if the use of a mobile dermatoscope is clinically relevant. The primary care physician, will record the photographs periodically, uploading the images to a Google Drive folder that the study sponsor will enable at the beginning of the study. The photographs are named using a code that includes the patient ID (NNN) and photograph number (nn). Primary care physicians will assess the patient\'s pathology as they would in a routine consultation and record their diagnosis and referral criteria, and associate them with the patient\'s photographs and demographic data to be collected by the research team telematically at the end of the study duration. These information transfers and the storage of the photographs will be in line with the European Regulation 2016/679 of 27 April on the protection of natural persons with regard to the processing of personal data and the free movement of such data and the Organic Law 3/2018 of 5 December on the Protection of Personal Data and guarantee of digital rights. The specialist physicians will have a period of one month after the end of the recruitment period to evaluate and label the photographs taken. In this labeling process they will record their diagnosis, and whether they consider that the referral has been appropriate or not. This information will be collected by the research team telematically at the end of the study duration. This transfer of information and storage of the photographs will comply with European Regulation 2016/679, of 27 April, on the protection of natural persons with regard to the processing of personal data and the free movement of such data and with Organic Law 3/2018, of 5 December, on the Protection of Personal Data and guarantee of digital rights.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 23, 2022
CompletedFirst Submitted
Initial submission to the registry
January 19, 2024
CompletedFirst Posted
Study publicly available on registry
January 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 6, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 6, 2025
CompletedJanuary 16, 2026
January 1, 2026
2.5 years
January 19, 2024
January 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of patients with inappropriate referrals
We define an inappropriate referral as one that, according to the criteria of the specialists consulted in the study, does not require the attention of a dermatologist in order to be treated, as may be the case of seborrheic keratosis. For this purpose, a photograph will be taken and the date of the patient's visit to the clinic and the criteria for moving to the next stage of the care process will be recorded
The moment of enrollment
Secondary Outcomes (5)
Demographical Data
The moment of enrollment
Data on the primary care physician
The moment of enrollment
Cost reduction
The moment of enrollment
Waiting list reduction
The moment of enrollment
Clinical data
The moment of enrollment
Study Arms (1)
Patients with any kind of skin pathologies
Adult patients (≥ 18 years) with skin pathologies seen in the primary care service of health centers referring to Cruces and Basurto University Hospitals. Patients participating in this study did not receive any specific treatment as part of the research protocol. Patients continued their regular prescribed medications and treatments as directed by their primary healthcare providers. No additional medications or treatments were administered as part of this study.
Eligibility Criteria
Adult patients (≥ 18 years) with any kind of skin pathology seen in the primary care service of health centers referring to Cruces and Basurto University Hospitals.
You may qualify if:
- Patients with skin pathologies.
- Patients aged 18 years or older.
- Patients who have signed the informed consent for the study.
You may not qualify if:
- Patient who at the investigator\'s discretion will not comply with the study procedures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AI Labs Group S.Llead
- Osakidetzacollaborator
- Servicio Vasco de Salud Osakidetza, Spaincollaborator
- Hospital de Crucescollaborator
Study Sites (1)
University Hospital of Cruces
Barakaldo, Biscay, 48903, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 19, 2024
First Posted
January 29, 2024
Study Start
November 23, 2022
Primary Completion
May 6, 2025
Study Completion
May 6, 2025
Last Updated
January 16, 2026
Record last verified: 2026-01